Masahiro Ono

ORCID

Publication Activity (10 Years)

Years Active: 2017-2023
Publications (10 Years): 30

Top Venues

Molecular pharmaceutics

ACS chemical neuroscience

Chemical communications (Cambridge, England)

Journal of medicinal chemistry

京都大学 / Kyoto University

This page only lists publications with an associated author ORCID identifier.

Affiliation History

京都大学 / Kyoto University Oct 1o 2017

Japan

教授 / Professor :: 薬学研究科 / Graduate Schools of Pharmaceutical Sciences

Publications

Kazuma Nakashima, Hiroyuki Watanabe, Masahiro Ono
Development of Novel Trifunctional Chelating Agents That Enhance Tumor Retention of Radioimmunoconjugates. Journal of medicinal chemistry (2023)
Takahiro Akasaka, Hiroyuki Watanabe, Masahiro Ono
In Vivo Near-Infrared Fluorescence Imaging Selective for Soluble Amyloid β Aggregates Using y-Shaped BODIPY Derivative. Journal of medicinal chemistry (2023)
Shohei Tsuchihashi, Kazuma Nakashima, Yuta Tarumizu, Hiroaki Ichikawa, Hiroki Jinda, Hiroyuki Watanabe, Masahiro Ono
Development of Novel 111 In/ 225 Ac-Labeled Agent Targeting PSMA for Highly Efficient Cancer Radiotheranostics. Journal of medicinal chemistry (2023)
Ryotaro Onoue, Hiroyuki Watanabe, Masahiro Ono
Hoechst-tagged radioiodinated BODIPY derivative for Auger-electron cancer therapy. Chemical communications (Cambridge, England) 59 (7) (2023)
Ryotaro Onoue, Hiroyuki Watanabe, Masahiro Ono
Hoechst-tagged radioiodinated BODIPY derivative for Auger-electron cancer therapy. Chemical communications (Cambridge, England) (2023)
Ryotaro Onoue, Hiroyuki Watanabe, Masahiro Ono
Hoechst-tagged radioiodinated BODIPY derivative for Auger-electron cancer therapy. Chemical communications (Cambridge, England) 59 (7) (2023)
Nobuki Kazuta, Hiroyuki Watanabe, Masahiro Ono
Synthesis and evaluation of 111 In-labeled tetrapeptide-based compounds as single-photon emission computed tomography imaging probes targeting granzyme B. Journal of labelled compounds & radiopharmaceuticals (2023)
Ryotaro Onoue, Hiroyuki Watanabe, Masahiro Ono
Hoechst-tagged radioiodinated BODIPY derivative for Auger-electron cancer therapy. Chemical communications (Cambridge, England) 59 (7) (2023)
Kohei Nakagawa, Hiroyuki Watanabe, Sho Kaide, Masahiro Ono
Structure-Activity Relationships of Styrylquinoline and Styrylquinoxaline Derivatives as α-Synuclein Imaging Probes. ACS medicinal chemistry letters 13 (10) (2022)
Shimpei Iikuni, Ichiro Kamei, Takaki Ohara, Hiroyuki Watanabe, Masahiro Ono
Development of an 111 In-Labeled Glucagon-Like Peptide-1 Receptor-Targeting Exendin-4 Derivative that Exhibits Reduced Renal Uptake. Molecular pharmaceutics 19 (3) (2022)
Sho Kaide, Hiroyuki Watanabe, Shimpei Iikuni, Masato Hasegawa, Masahiro Ono
Synthesis and Evaluation of 18 F-Labeled Chalcone Analogue for Detection of α-Synuclein Aggregates in the Brain Using the Mouse Model. ACS chemical neuroscience 13 (20) (2022)
Kazuma Nakashima, Shimpei Iikuni, Hiroyuki Watanabe, Masahiro Ono
Application of the Chelator-Based Clickable Radiotheranostic Platform to Moderate-Molecular-Weight Ligands. ACS medicinal chemistry letters 13 (10) (2022)
Shimpei Iikuni, Yuta Tarumizu, Shohei Tsuchihashi, Takaki Ohara, Hiroyuki Watanabe, Masahiro Ono
Synthesis and Evaluation of Novel 111 In-Labeled Picolinic Acid-Based Radioligands Containing an Albumin Binder for Development of a Radiotheranostic Platform. Molecular pharmaceutics 19 (8) (2022)
Shimpei Iikuni, Takaki Ohara, Hiroyuki Watanabe, Masahiro Ono
Structure-Activity Relationships and Pharmacokinetics of 111 In-Labeled Glucagon-like Peptide-1 Receptor-Targeting Exendin-4 Derivatives Conjugated with Albumin Binder Moieties. Molecular pharmaceutics 19 (8) (2022)
Hiroyuki Watanabe, Rinka Maekawa, Shimpei Iikuni, Masashi Kakae, Nagisa Matsuo, Hisashi Shirakawa, Shuji Kaneko, Masahiro Ono
Characterization of Radioiodinated Diaryl Oxadiazole Derivatives as SPECT Probes for Detection of Myelin in Multiple Sclerosis. ACS chemical neuroscience 13 (3) (2022)
Hiroyuki Watanabe, Takeaki Kishimoto, Sho Kaide, Yuta Tarumizu, Haruka Tatsumi, Shimpei Iikuni, Masahiro Ono
Characterization and Optimization of Benzimidazopyrimidine and Pyridoimidazopyridine Derivatives as Tau-SPECT Probes. ACS medicinal chemistry letters 12 (5) (2021)
Shimpei Iikuni, Yuta Tarumizu, Kazuma Nakashima, Yusuke Higaki, Hiroaki Ichikawa, Hiroyuki Watanabe, Masahiro Ono
Radiotheranostics Using a Novel 225Ac-Labeled Radioligand with Improved Pharmacokinetics Targeting Prostate-Specific Membrane Antigen. Journal of medicinal chemistry 64 (18) (2021)
Kazuma Nakashima, Shimpei Iikuni, Hiroyuki Watanabe, Masahiro Ono
Development of a novel radiotheranostic platform with a DOTA-based trifunctional chelating agent. Chemical communications (Cambridge, England) 57 (52) (2021)
Shimpei Iikuni, Yuya Okada, Yoichi Shimizu, Hiroyuki Watanabe, Masahiro Ono
Modulation of the Pharmacokinetics of a Radioligand Targeting Carbonic Anhydrase-IX with Albumin-Binding Moieties. Molecular pharmaceutics 18 (3) (2021)
Sho Kaide, Hiroyuki Watanabe, Shimpei Iikuni, Masato Hasegawa, Kyoko Itoh, Masahiro Ono
Chalcone Analogue as New Candidate for Selective Detection of α-Synuclein Pathology. ACS chemical neuroscience 13 (1) (2021)
Sho Kaide, Hiroyuki Watanabe, Yoichi Shimizu, Shimpei Iikuni, Yuji Nakamoto, Masato Hasegawa, Kyoko Itoh, Masahiro Ono
Identification and Evaluation of Bisquinoline Scaffold as a New Candidate for α-Synuclein-PET Imaging. ACS chemical neuroscience 11 (24) (2020)
Ryoko Kawai, Shuntaro Chiba, Koji Okuwaki, Ryo Kanada, Hideo Doi, Masahiro Ono, Yuji Mochizuki, Yasushi Okuno
Stabilization Mechanism for a Nonfibrillar Amyloid β Oligomer Based on Formation of a Hydrophobic Core Determined by Dissipative Particle Dynamics. ACS chemical neuroscience 11 (3) (2020)
Hiroyuki Watanabe, Kiyoshiro Kawano, Yoichi Shimizu, Shimpei Iikuni, Yuji Nakamoto, Kaori Togashi, Masahiro Ono
Development of Novel PET Imaging Probes for Detection of Amylin Aggregates in the Pancreas. Molecular pharmaceutics 17 (4) (2020)
Shimpei Iikuni, Keiichi Tanimura, Hiroyuki Watanabe, Yoichi Shimizu, Hideo Saji, Masahiro Ono
Development of the 99mTc-Hydroxamamide Complex as a Probe Targeting Carbonic Anhydrase IX. Molecular pharmaceutics 16 (4) (2019)
Hiroyuki Watanabe, Naoki Matsushita, Yoichi Shimizu, Shimpei Iikuni, Yuji Nakamoto, Kaori Togashi, Masahiro Ono
Synthesis and characterization of a novel 18F-labeled 2,5-diarylnicotinamide derivative targeting orexin 2 receptor. MedChemComm 10 (12) (2019)
Takeshi Fuchigami, Masao Kawasaki, Ryusuke Koyama, Mari Nakaie, Takehiro Nakagaki, Kazunori Sano, Ryuichiro Atarashi, Sakura Yoshida, Mamoru Haratake, Masahiro Ono, Noriyuki Nishida, Morio Nakayama
Development of Radioiodinated Benzofuran Derivatives for in Vivo Imaging of Prion Deposits in the Brain. ACS infectious diseases 5 (12) (2019)
Ryoko Kawai, Mitsugu Araki, Masashi Yoshimura, Narutoshi Kamiya, Masahiro Ono, Hideo Saji, Yasushi Okuno
Core Binding Site of a Thioflavin-T-Derived Imaging Probe on Amyloid β Fibrils Predicted by Computational Methods. ACS chemical neuroscience 9 (5) (2018)
Kohei Sano, Yuko Kanada, Katsushi Takahashi, Ning Ding, Kengo Kanazaki, Takahiro Mukai, Masahiro Ono, Hideo Saji
Enhanced Delivery of Radiolabeled Polyoxazoline into Tumors via Self-Aggregation under Hyperthermic Conditions. Molecular pharmaceutics 15 (9) (2018)
Hiroyuki Watanabe, Masashi Yoshimura, Kohei Sano, Yoichi Shimizu, Sho Kaide, Yuji Nakamoto, Kaori Togashi, Masahiro Ono, Hideo Saji
Characterization of Novel 18F-Labeled Phenoxymethylpyridine Derivatives as Amylin Imaging Probes. Molecular pharmaceutics 15 (12) (2018)
Hiroyuki Watanabe, Masahiro Ono, Taisuke Ariyoshi, Rikako Katayanagi, Hideo Saji
Novel Benzothiazole Derivatives as Fluorescent Probes for Detection of β-Amyloid and α-Synuclein Aggregates. ACS chemical neuroscience 8 (8) (2017)

Masahiro Ono.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Masahiro Ono